Armed with 3 FDA approvals since the pandemic outbreak, Aidoc adds $20M to Series B
Oshry Alkeslasi
The global COVID crisis has only accelerated Aidoc's opportunities, as the company leverages 3 FDA approvals for AI-powered diagnostics tools into exponential growth since the pandemic outbreak......